Skip to main content
MariMed Inc. logo

MariMed Inc. — Investor Relations & Filings

Ticker · MRMD ISIN · US56782V1070 CSE Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country CA Canada
Listing CSE MRMD

About MariMed Inc.

https://www.marimedinc.com/

MariMed Inc. is a leading multi-state cannabis operator (MSO) and brand innovator focused on the seed-to-sale lifecycle. The company develops, owns, and manages state-licensed facilities that serve as models of excellence for cultivation, production, and retail operations. MariMed is dedicated to creating high-quality, award-winning cannabis products designed to promote wellness and improve lives. Its diverse portfolio of branded products caters to a broad target market, including both wellness seekers and lifestyle enthusiasts. The company operates retail dispensaries that provide premium products and expert guidance. Furthermore, MariMed has expanded its business activities to include the production and sale of hemp-derived THC products, leveraging its established brands for new market penetration.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 90% confidence The document is Exhibit 31.1, a CEO certification under SOX 302 for the company’s Form 10-Q. It contains only an officer’s attestation and no substantive financial data or report content. Under the Certification Rule, officer attestations are classified as Regulatory Filings (RNS), not as the underlying 10-Q report.
2026-05-15 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 90% confidence The document is the full quarterly report on Form 10-Q for MariMed Inc., containing Management’s Discussion and Analysis, condensed consolidated financial statements, critical accounting policies, forward-looking statements, and acquisition details. It is not a brief earnings release or a notice announcing publication of a report, but the actual interim financial report for the quarter. Therefore, it should be classified as an Interim/Quarterly Report (code IR). Q1 2026
2026-05-15 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 96% confidence The document is labeled “FORM 10-Q” and is a quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act, covering the period ended March 31, 2026. It includes unaudited condensed consolidated financial statements (balance sheet, statement of operations, cash flows), notes, and MD&A. This is a full interim/quarterly report, not merely an announcement or summary. Therefore, it is classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 English
Material change report - English.pdf
Earnings Release Classification · 92% confidence The document is a Form 8-K “Current Report” filed to disclose the company’s press release announcing its first quarter 2026 financial results (Item 2.02 “Results of Operations and Financial Condition”). It contains the initial announcement of quarterly/period financial highlights and commentary, not a full quarterly report (10-Q). This matches our definition of an Earnings Release (ER). Q1 2026
2026-05-14 English
News release - English.pdf
Earnings Release Classification · 92% confidence The document is a press release dated May 13, 2026 announcing MariMed’s first quarter 2026 financial results. It contains the headline “MariMed Reports First Quarter 2026 Earnings,” key financial highlights, management commentary, conference call details, and condensed financial statements. This format and content match an initial quarterly earnings announcement rather than a full interim report or regulatory filing. Therefore, it is classified as an Earnings Release. Q1 2026
2026-05-13 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a proxy card and accompanying voting instructions for the Annual Meeting of Stockholders, including the Notice of Availability of Proxy Materials and Proxy Statement. It is soliciting shareholder votes and providing instructions for submitting proxies, which falls under Proxy Solicitation & Information Statement (PSI).
2026-04-23 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.